Key Players
Competitive Landscape
Pregnancy heartburn nutrition draws four distinct business models: global OTC brand owners, consumer-health portfolio groups, private-label manufacturers and retailer-controlled labels. The field spans direct antacid brands and store-label acid reducers beside pregnancy-screened self-care offers.
Portfolio competition became more visible in 2026 as large brands and retailers refreshed distinct heartburn formats instead of one core tablet line. Haleon updated a TUMS raspberry-lemonade chewable filing with DailyMed in February 2026. Walgreen Co. updated a liquid antacid filing for heartburn relief in January 2026. Those actions show that format coverage and current regulated directions matter ahead of pregnancy-specific messaging during conversion.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| May 2026: CVS Pharmacy, Inc. updated its Supreme liquid antacid label with calcium carbonate and magnesium hydroxide. | Some users prefer liquid dosing when chewable texture becomes unattractive during pregnancy. | Large pharmacy chains maintain several antacid dosage routes beside national brands. | Liquid antacids give retail pharmacies another format for symptom-led self-care. |
| January 2026: Walmart Inc. updated assorted-fruit calcium-carbonate antacid chews under its retailer-controlled label. | Value-sensitive shoppers can remain inside one retailer while changing the heartburn format they purchase. | Mass retailers keep calcium-carbonate chewables current beside separate acid-reducer lines. | Retailer-label antacids retain repeat purchases without moving shoppers to a national brand. |
| July 2026: Valu Merchandisers Company updated Best Choice Extra Strength Berry Flavor with antacid and anti-gas actives. | Regional grocers need shelf-ready antacids with familiar actives and simple heartburn claims. | Wholesale-controlled labels extend regulated antacid supply beyond national drugstore chains. | Regional retail networks monetize value-led heartburn demand without building a proprietary formulation platform. |
Kenvue, Perrigo and Meijer broaden the field outside the table through acid-reducer and dual-action routes that extend choice beyond single-class calcium antacids.
Source: Future Market Insights, Pregnancy Heartburn Nutrition Market and OTC Heartburn Drugs Market Reports, 2026-2036.
Profiled companies collectively cover immediate antacid relief, combined acid-reducer formats, liquids and retailer-controlled labels instead of depending on one pregnancy-only product architecture.
Who leads the Pregnancy Heartburn Nutrition Market?
No public company-share ranking supports a single market leader in this article. Haleon and Kenvue hold the clearest branded positions in direct OTC heartburn relief among the profiled companies.
Which suppliers have documented qualification or quality approvals?
Haleon, Kenvue, Procter & Gamble, CVS Pharmacy, Walgreen Co., Walmart and Perrigo maintain current USA regulated heartburn label records.
Which companies provide portable heartburn relief products?
Haleon, Kenvue, Procter & Gamble, CVS Pharmacy and Walmart document chewable or other low-preparation heartburn formats in current regulated records.
Which suppliers serve North America and Europe?
Haleon, Kenvue and Perrigo operate consumer-health portfolios in North America and Europe while the profiled retailer-label companies are concentrated in the United States.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Haleon (Tums) | Global branded antacid portfolio. | July 2026: DailyMed updated TUMS Ultra with a calcium-carbonate chewable filing for heartburn relief. |
| Kenvue (Pepcid) | Global acid-reducer and antacid portfolio. | February 2026: DailyMed updated Pepcid AC Original Strength with current heartburn relief and prevention directions. |
| Procter & Gamble (Rolaids) | USA branded multi-mineral antacid portfolio. | July 2026: DailyMed updated Rolaids Max Strength 1500 with current calcium-carbonate chewable heartburn directions. |
| CVS Pharmacy, Inc. | USA retailer-controlled antacid portfolio. | January 2026: DailyMed updated CVS Health Extra Strength Sugar Free Antacid with a calcium-carbonate chewable heartburn filing. |
| Walgreen Co. | USA pharmacy retailer with liquid and dual-action heartburn routes. | March 2026: DailyMed updated Acid Reducer Complete with famotidine plus antacid actives for heartburn relief. |
| Walmart Inc. | Mass-retail private-label antacid portfolio. | April 2026: DailyMed updated Equate Famotidine with current heartburn relief and prevention directions. |
| Meijer Distribution Inc. | USA retailer with dual-action antacid and acid-reducer formats. | January 2026: DailyMed updated Dual Action Complete with famotidine, calcium carbonate and magnesium hydroxide in a chewable heartburn filing. |
| Costco Wholesale Company (Kirkland Signature) | Warehouse-club retailer with an OTC acid-reducer private label. | February 2025: DailyMed updated Kirkland Signature Acid Controller with famotidine for heartburn relief and prevention. |
Research Methodology
The companies mapped here illustrate the pregnancy heartburn nutrition market structure instead of an exhaustive ranking. Inclusion requires current verifiable evidence that a company supplies non-prescription heartburn relief products within the defined pregnancy self-care boundary. Evidence comes from regulatory filings, approved label records, company announcements and public filings. Capabilities are attributed to the stated Tums, Pepcid, Rolaids, store-brand antacid or acid-reducer line instead of broader corporate portfolios. Market-share estimates remain proprietary FMI assessments for the complete 2026-2036 forecast period covered by this article.
